Hot Keywords
Biomarker Discovery Autophagy and Cancer Breast Cancer Metastasis Brain Metastases Gastric Cancer Metastasis Lung Cancer Genetic Heterogeneity Colorectal Cancer Prostate Cancer Cancer Immunotherapy Circulating Tumor Cells Neuroendocrine Tumors

Top

Chair(s)

  • Prof. Hendrik Paul Van Poppel

    European Association of Urology (EAU), Dept Urology, University Hospital KU Leuven, Belgium.

    Professor Hendrik Paul Van Poppel is the Chairman of the Department of Urology at the University Hospital Gasthuisberg, Katholieke Universiteit (KU) Leuven. He is a Board Member of the European Association of Urology (EAU), Chairman of the Educational Office of the EAU and Director of the European School of Urology. He is also a member of the American Association of Genito-Urinary Surgeons, Chairman of the Scientific Committee of Europa Uomo, and Faculty Member of the European Society of Medical Oncology.

Speakers

  • Dr. Michael B. Atkins

    Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., United States.
    Topic: Current and Emerging Therapies for First Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma

    Michael B. Atkins, MD, is deputy director of the Georgetown Lombardi Comprehensive Cancer Center and the Scholl Professor and vice chair of the Department of Medical Oncology at Georgetown University Medical Center. He is an internationally recognized expert in the management of patients with high-risk and metastatic melanoma or kidney cancer.

  • Dr. Logan Briggs

    Harvard Medical School, Boston, United States.
    Topic: Prognostic and Predictive Biomarkers for Metastatic Renal Cell Carcinoma

    Dr. Logan Briggs is currently studying at Harvard Medical School and is engaged in scientific research in the field of metastatic clear cell renal cell carcinoma. In addition, he is the Chairman of the Board and the co-founder of Medicine in Motion (MM). As the co-founder of MM, he is committed to combating professional burnout in the medical profession by promoting fitness, community building and charity. To date, the organization has raised $45,000 for cancer research.

  • Dr. Bambang T. Atmaja

    The Royal London Hospital, London, United Kingdom
    Topic: Individualized Therapy for Metastatic Renal Cell Carcinoma

    Dr. Bambang T. Atmaja is from The Royal London Hospital and he is a clinical researcher in the Department of Oncology at Royal Marsden Hospital. He is also doing an internship at the St. Luke Cancer Center at Royal Surrey County Hospital now.

Moments

Presentation

  • Dr. Michael B. Atkins
    Topic: Current and Emerging Therapies for First Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma
  • Dr. Logan Briggs
    Topic: Prognostic and Predictive Biomarkers for Metastatic Renal Cell Carcinoma
  • Dr. Bambang T. Atmaja
    Topic: Individualized Therapy for Metastatic Renal Cell Carcinoma
  • Heated Discussion
© 2016-2021 OAE Publishing Inc., except certain content provided by third parties